Clinical Scorecard: Structural Brain Biomarkers Prior to Treatment as Predictors of Response to Repetitive Transcranial Magnetic Stimulation in Subjective Tinnitus
At a Glance
Category
Detail
Condition
Subjective Tinnitus
Key Mechanisms
Structural brain alterations and neuroplastic changes induced by rTMS.
Target Population
Patients with subjective tinnitus.
Care Setting
Clinical neuromodulation and neuroimaging.
Key Highlights
56.25% of patients classified as responders to rTMS.
Right pars triangularis of the inferior frontal gyrus identified as a key predictor.
Predictive model achieved AUC of 0.85 and accuracy of 0.77.
Responders showed larger gray matter volume in specific brain regions compared to non-responders and healthy controls.
No robust correlation found between structural features and baseline clinical measures.
Guideline-Based Recommendations
Diagnosis
Utilize high-resolution T1-weighted structural MRI to assess brain features.
Management
Consider pre-treatment brain structural biomarkers for rTMS efficacy prediction.
Monitoring & Follow-up
Evaluate changes in brain structure post-rTMS treatment.
Risks
Potential variability in rTMS response among patients.
Patient & Prescribing Data
64 patients with subjective tinnitus and 18 healthy controls.
Pre-treatment assessment of brain structure may guide individualized rTMS treatment.
Clinical Best Practices
Incorporate neuroimaging findings into treatment planning for tinnitus.
Use machine learning models to enhance predictive accuracy for rTMS outcomes.
